DNA X Q1 2026: asset sale nets $6.3M; no continuing revenue; raises $1.8M debt

DNA X, Inc.

Completed sale of mobile device assets to NEXA for $15M (net $13.5M after working capital adj); $12M paid, $1.5M due Oct 2026.
Net income of $6.3M from asset sale (taxes, fees, severance); no revenue from continuing operations.
G&A expenses from continuing ops $3.6M, including $1.5M severance and $0.9M audit/tax costs.
Cash from continuing ops $1.2M at quarter end; entered agreement for $1.8M new debt on May 20, 2026.
Rebranded from Sonim Technologies to DNA X, Inc.; focuses on AI/crypto trading platform.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

DNA X, Inc. reported first quarter ended March 31, 2026 results: revenue There was no revenue from continuing operations because revenue from our phone and hotspot operations was included in di, net income $6.3 million in net income for the first quarter of 2026.

Period: first quarter ended March 31, 2026
Revenue: There was no revenue from continuing operations because revenue from our phone and hotspot operations was included in di
Net income: $6.3 million in net income for the first quarter of 2026
Result: reported results

Exact text from the filing

DNA X, Inc. Reports First Quarter 2026 Financial Results ● Closed sale of the Company’s mobile device assets to NEXA in January 2026 ● Completed the transfer of the operations of the phone and hotspot business to NEXA ● Focused on enhancing the DNA X trading platform to prepare the platform for its initial growth phase

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

DNA X, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-024639

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.